Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.
PrEP including VicPrEP
Iryna Zablotska gave a conservative estimate of the number of people in Australia who will be likely to start PrEP if it is approved by the TGA. She also highlighted some of the difficulties in making such estimates.
John de Witt gave two interesting presentations on data from the VicPrEP trial. His first presentation outlined their findings on "risk compensation" in those on PrEP. They found a modest decrease in condom use with casual sexual partners amongst VicPrEP participants. Reassuringly, they also found good self-reported PrEP adherence, so the reduction in condom use will hopefully not translate into an increase in HIV risk.
John's second presentation provided a summary of the experiences reported by people taking PrEP. Participants reported increased enjoyment of sex, but also reported some reluctance to inform sex partners that they were taking PrEP. The latter suggests the emergence of stigma, or perceived stigma, associated with PrEP use.